[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES8303316A1 - Disulfide type cysteine derivatives - Google Patents

Disulfide type cysteine derivatives

Info

Publication number
ES8303316A1
ES8303316A1 ES505628A ES505628A ES8303316A1 ES 8303316 A1 ES8303316 A1 ES 8303316A1 ES 505628 A ES505628 A ES 505628A ES 505628 A ES505628 A ES 505628A ES 8303316 A1 ES8303316 A1 ES 8303316A1
Authority
ES
Spain
Prior art keywords
pct
image
date
cysteine derivatives
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES505628A
Other languages
Spanish (es)
Other versions
ES505628A0 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of ES505628A0 publication Critical patent/ES505628A0/en
Publication of ES8303316A1 publication Critical patent/ES8303316A1/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
    • C07C319/12—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by reactions not involving the formation of mercapto groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/12—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms
    • C07C321/14—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/36—Seven-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

PCT No. PCT/JP81/00235 Sec. 371 Date May 4, 1982 Sec. 102(e) Date May 4, 1982 PCT Filed Sep. 18, 1981 PCT Pub. No. WO82/01000 PCT Pub. Date Apr. 1, 1982.Pharmaceutically active compounds and pharmaceutically acceptable salts thereof having the following formulae < IMAGE > < IMAGE > < IMAGE > wherein A is a straight or branched chain alkylene group containing 1 to 3 carbon atoms and R7 and R8 is each a lower alkyl group. These compounds are useful as the active component of pharmacological preparations.
ES505628A 1980-09-20 1981-09-18 Disulfide type cysteine derivatives Expired ES8303316A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP55131349A JPS5756454A (en) 1980-09-20 1980-09-20 Disulfide type cysteine derivative

Publications (2)

Publication Number Publication Date
ES505628A0 ES505628A0 (en) 1983-02-01
ES8303316A1 true ES8303316A1 (en) 1983-02-01

Family

ID=15055849

Family Applications (1)

Application Number Title Priority Date Filing Date
ES505628A Expired ES8303316A1 (en) 1980-09-20 1981-09-18 Disulfide type cysteine derivatives

Country Status (13)

Country Link
US (1) US4517123A (en)
JP (1) JPS5756454A (en)
KR (1) KR880000041B1 (en)
AU (1) AU7590081A (en)
BE (1) BE890399A (en)
CA (1) CA1162188A (en)
DE (1) DE3152362C2 (en)
ES (1) ES8303316A1 (en)
FR (1) FR2490637A1 (en)
GB (1) GB2096145B (en)
IT (1) IT1138226B (en)
SE (1) SE447379B (en)
WO (1) WO1982001000A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2012958A6 (en) * 1988-01-25 1990-04-16 Santen Pharmaceutical Co Ltd Cysteine derivatives.
US5041435A (en) * 1988-08-13 1991-08-20 Santen Pharmaceutical Co., Ltd. Cyclic sulfur-containing compounds
US5081307A (en) * 1989-07-14 1992-01-14 Kawaguchi Chemical Co., Ltd. Process for preparing 2,2-dimethoxy-2-phenylacetophenone
JP2720217B2 (en) * 1989-12-05 1998-03-04 参天製薬株式会社 Sulfur-containing amino acid derivatives
US5175256A (en) * 1990-09-28 1992-12-29 Neorx Corporation Protein labeling reagents
JP2843955B2 (en) * 1992-08-01 1999-01-06 参天製薬株式会社 Anti-cataract agent
US5670545A (en) * 1996-02-09 1997-09-23 Board Of Regents Of The University Of Colorado Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species
US10655227B2 (en) 2017-10-06 2020-05-19 Rohm And Haas Electronic Materials Llc Stable electroless copper plating compositions and methods for electroless plating copper on substrates
US10294569B2 (en) 2017-10-06 2019-05-21 Rohm And Haas Electronic Materials Llc Stable electroless copper plating compositions and methods for electroless plating copper on substrates

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5271928A (en) * 1975-12-11 1977-06-15 Sony Corp Receiving and recording unit of tv signals
JPS535112A (en) * 1976-03-08 1978-01-18 Santen Pharmaceutical Co Ltd New cysteine derivatives
JPS545916A (en) * 1977-06-17 1979-01-17 Santen Pharmaceutical Co Ltd Novel cystein derivative
JPS6058908B2 (en) * 1978-10-11 1985-12-23 参天製薬株式会社 cysteine derivative
JPS6011888B2 (en) * 1978-10-11 1985-03-28 参天製薬株式会社 Rheumatic disease treatment drug

Also Published As

Publication number Publication date
BE890399A (en) 1982-01-18
KR830007539A (en) 1983-10-21
IT1138226B (en) 1986-09-17
ES505628A0 (en) 1983-02-01
AU7590081A (en) 1982-04-14
WO1982001000A1 (en) 1982-04-01
IT8124057A0 (en) 1981-09-21
KR880000041B1 (en) 1988-02-20
SE447379B (en) 1986-11-10
JPS5756454A (en) 1982-04-05
DE3152362C2 (en) 1986-08-28
US4517123A (en) 1985-05-14
CA1162188A (en) 1984-02-14
SE8203053L (en) 1982-05-14
FR2490637A1 (en) 1982-03-26
FR2490637B1 (en) 1984-12-14
GB2096145A (en) 1982-10-13
GB2096145B (en) 1984-05-02
DE3152362T1 (en) 1982-10-07
JPS6143350B2 (en) 1986-09-26

Similar Documents

Publication Publication Date Title
US4302465B1 (en)
CO4770945A1 (en) ANTI-PLAQUE ORAL COMPOSITIONS CONTAINING ALKYLATED PHENOL- ANTIBACTERIAL
ES2000346A6 (en) Distamycin derivatives and process for their preparation
IE45576L (en) Analgesic tetrapeptides and pentapeptides
ES8303316A1 (en) Disulfide type cysteine derivatives
DK288686A (en) PHARMACEUTICAL PREPARATIONS
ES8404360A1 (en) 7-Acylamino-3-cephem-4-carboxylic acid derivatives, processes for the preparation of the same and pharmaceutical composition comprising the same.
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
NO164351C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-ALKYL-L-PHENYL-2-PIPERAZINOALKYLPYRAZOLINE-3-ON COMPOUNDS.
ES8604604A1 (en) 3, 3&#34;, 4&#34; -Tri-O-acylspiramycin I.
ES481551A1 (en) Bis(aryloxy-alcanecarboxylic compounds, their preparation and their therapeutic use.
ES8702433A1 (en) Peptide-substituted heterocyclic immunostimulants.
ES8506304A1 (en) Piperazine derivatives and a medicine containing the same
SE8304545D0 (en) BENZAMIDE DERIVATIVES
ES8704918A1 (en) Phosphate ester derivatives, and their use as anti-cancer agents.
ES8200648A2 (en) Ionic polyiodo benzene derivatives useful as X-ray contrast media
DE3268541D1 (en) Benzodioxane-imidazoline compounds, their preparation and use
ES8401761A1 (en) 1-(3,4,5-Trimethoxycinnamoyl)-4-aminocarbonylethyl-substituted piperazine derivatives and a process for the preparation thereof.
GB1250348A (en)
ES8301931A1 (en) Imidazoles.
SE7412163L (en)
ES8702392A1 (en) Thiadiazinone compounds, process for their preparation, and pharmaceutical compositions containing them.
DE69108326D1 (en) 15-deoxyprostaglandinderivat.
ES8500619A1 (en) Eburnane-oxime derivatives
IL67564A0 (en) (1,2)-fused 1,4-benzodiazepine compounds,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20010201